Risk isn't just probability but amplitude (of detriment) also. Opportunity is mirror image for probability but not necessarily amplitude. Few see this symmetry or non-symmetry. Latter can confer net risk-adjusted opportunity. Opportunity from risk itself. Risk is feature not bug
@dawallach@LocasaleLab New Anticancer Drug Selectively Harms Cancer and May Slow Aging - you won't fund this and so consider yourself part of the problem
https://t.co/5ybbEN79oW
Risk isn't just probability but amplitude (of detriment) also. Opportunity is mirror image for probability but not necessarily amplitude. Few see this symmetry or non-symmetry. Latter can confer net risk-adjusted opportunity. Opportunity from risk itself. Risk is feature not bug
Investing has a risk but people rarely factor in that not investing has a risk also, which isn't capped, and in this case may include an earlier death!
@JimRice1111 Face first into longevity.
That is the initial wedge.
The company is a drug discovery platform, with new invented, patented drugs! E.g., for cancer and (to predict) longevity.
And done all this with next to nothing. Think what it could do with income!
We're PhD qualified scientists - including Prof. George Church (Harvard Medical School) - who've
Discovered why different species have different lifespans, how nature modifies aging rate, & so how we can too.
Nature's aging rate dial is IF1 protein, species with more age slower, & live longer.
Now in skincare: https://t.co/n35aApo8mK
@garrytan Discovered why different species have different lifespans, how nature modifies aging rate, & so how we can too.
Nature's aging rate dial is IF1 protein, species with more age slower, & live longer.
Now in skincare: https://t.co/MfEszb8L5l
@alexisohanian I'm a PhD-qualified scientist whose
Discovered why different species have different lifespans, how nature modifies aging rate, & so how we can too.
Nature's aging rate dial is IF1 protein, species with more age slower, & live longer.
It in skincare: https://t.co/MfEszb8L5l